1. Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report. Issue 3 (18th January 2021) Authors: Mazzaschi, Giulia; Tommasi, Chiara; Pietri, Elisabetta; Corcione, Luigi; De Giorgi, Annamaria; Bini, Paola; Bui, Simona Journal: Clinical case reports Issue: Volume 9:Issue 3(2021) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab. (8th June 2018) Authors: Facchinetti, Francesco; Veneziani, Michele; Buti, Sebastiano; Gelsomino, Francesco; Squadrilli, Anna; Bordi, Paola; Bersanelli, Melissa; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Mazzaschi, Giulia; Leonardi, Francesco; Quaini, Federico; Ardizzoni, Andrea; Missale, Gabriele; Tiseo, Marcello Journal: Immunotherapy Issue: Volume 10:Number 8(2018) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study. (September 2021) Authors: Buti, Sebastiano; Perrone, Fabiana; Zielli, Teresa; Mazzaschi, Giulia; Casartelli, Chiara; Leonetti, Alessandro; Milanese, Gianluca; Silva, Mario; Eufrasia Ledda, Roberta; Musolino, Antonino; Pucci, Francesca; Bersanelli, Melissa; Tiseo, Marcello Journal: Clinical medicine insights. Oncology Issue: Volume 15(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cytoreductive nephrectomy in the era of targeted- And immuno- therapy for metastatic renal cell carcinoma: An elusive issue? A systematic review of the literature. (April 2021) Authors: Mazzaschi, Giulia; Quaini, Federico; Bersanelli, Melissa; Buti, Sebastiano Journal: Critical reviews in oncology/hematology Issue: Volume 160(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status. (May 2020) Authors: Facchinetti, Francesco; Mazzaschi, Giulia; Barbieri, Fausto; Passiglia, Francesco; Mazzoni, Francesca; Berardi, Rossana; Proto, Claudia; Cecere, Fabiana Letizia; Pilotto, Sara; Scotti, Vieri; Rossi, Sabrina; Del Conte, Alessandro; Vita, Emanuele; Bennati, Chiara; Ardizzoni, Andrea; Cerea, Giulio;... Journal: European journal of cancer Issue: Volume 130(2020) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors. (January 2018) Authors: Savi, Monia; Frati, Caterina; Cavalli, Stefano; Graiani, Gallia; Galati, Serena; Buschini, Annamaria; Madeddu, Denise; Falco, Angela; Prezioso, Lucia; Mazzaschi, Giulia; Galaverna, Federica; Lagrasta, Costanza Anna Maria; Corradini, Emilia; De Angelis, Antonella; Cappetta, Donato; Berrino, Libera... Journal: Pharmacological research Issue: Volume 127(2018) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC. (June 2020) Authors: Mazzaschi, Giulia; Milanese, Gianluca; Pagano, Paolo; Madeddu, Denise; Gnetti, Letizia; Trentini, Francesca; Falco, Angela; Frati, Caterina; Lorusso, Bruno; Lagrasta, Costanza; Minari, Roberta; Ampollini, Luca; Silva, Mario; Sverzellati, Nicola; Quaini, Federico; Roti, Giovanni; Tiseo, Marcello Journal: Lung cancer Issue: Volume 144(2020) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer. (September 2019) Authors: Leonetti, Alessandro; Wever, Birgit; Mazzaschi, Giulia; Assaraf, Yehuda G.; Rolfo, Christian; Quaini, Federico; Tiseo, Marcello; Giovannetti, Elisa Journal: Drug resistance updates Issue: Volume 46(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-92 GPS as a prognostic index and a predictor of toxicity in early or locally advanced head and neck cancer patients treated with radiotherapy or definitive chemoradiotherapy. (July 2021) Authors: Bui, Simona; Pietri, Elisabetta; de Corianò, Matil; Luca, Isella; Mazzaschi, Giulia; Tommasi, Chiara; Garajovà, Ingrid; Grondelli, Claudia Journal: Oral oncology Issue: Volume 118(2021)Supplement Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Issue 1 (February 2022) Authors: Minari, Roberta; Bonatti, Francesco; Mazzaschi, Giulia; Dodi, Alessandra; Facchinetti, Francesco; Gelsomino, Francesco; Cinquegrani, Gloria; Squadrilli, Anna; Bordi, Paola; Buti, Sebastiano; Bersanelli, Melissa; Leonetti, Alessandro; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Quaini, Fede... Journal: Tumori Issue: Volume 108:Issue 1(2022) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗